Estrogens and schizophrenia

Estrogen Effects in Psychiatric Disorders

Volumn , Issue , 2005, Pages 31-52

  Riecher Rössler, Anita ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845234274     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-211-27063-9_2     Document Type: Chapter

References (90)

1. Ahokas AJ, Turtiainen S, Aito M (1998) Sublingual oestrogen treatment of postnatal depression. Lancet 351: 109.
2. Ahokas A, Aito M, Turtiainen S (2000) Association between oestradiol and puerperal psychosis. Acta Psychiatr Scand 101: 167-170.
3. Barrett-Connor E, Stuenkel CA (2001) Hormone replacement therapy (HRT): risks and benefits. Int J Epidemiol 30: 423-426.
4. Bédard P, Boucher R, Daigle M, Di Paolo T (1984) Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoendocrinology 9: 375-379.
5. Bergemann N, Mundt Ch, Resch F, Parzer P, Nagl I, Eller A, Runnebaum B (1996) On the hypoestrogen hypothesis in female schizophrenia: Preliminary results. Schizophr Res 18: 158.
6. Bergemann N, Parzer P, Nagl I, Salbach B, Runnebaum B, Mundt Ch, Resch F (2002) Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Women Ment Health 5: 119-126.
7. Bleuler M (1943) Die spätschizophrenen Krankheitsbilder. Neurol XV 9: 259-290.
8. Braendle W, Breckwoldt M, Kuhl H, Riecher-Rössler A, Rohde A, Rüther E (2001) Sexualhormone und Psyche - Ergebnisse des 2. Interdisziplinären Frankfurter Gesprächs zur Kontrazeption. Frauenarzt 42: 154-160.
9. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 111: 11-20.
10. Carter DA, McGarrick GM, Norton KRW, Paykel ES, Prysor-Jones RA, Whitehead SA (1982) The effect of chronic neuroleptic treatment on gonadotrophin release. Psychoneuroendocrinology 7: 201-207.
11. Chang SS, Renshaw DC (1986) Psychosis and pregnancy. Compr Ther 12: 36-41.
12. Choi SH, Kang SB, Joe SH (2001) Changes in premenstrual symptoms in women with schizophrenia: A prospective study. Psychosom Med 6: 822-829.
13. Cohen RZ, Seeman MV, Gotowiec A, Kopala L (1999) Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry 156: 1059-1064.
14. Cyr M, Calon F, Morissette M, Di Paolo T (2002) Estrogenic modulation of brain activity: Implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 27: 12-27.
15. Davis SR (2002) The effects of tibolone on mood and libido. Menopause 9: 162-170.
16. De Battista C, Lawrence Smith D, Schatzberg AF (1999) Modulation of monoamine neurotransmitters by estrogen: Clinical implications. Rev Psychiatry 18: 137-166.
17. de Noaves Soares C, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 58: 529-534.
18. Diczfalusy E, Lauritzen C (1961) Psychiatrische und neurologische Erkrankungen. In: Diczfalusy E, Lauritzen C (eds) Östrogene beim Menschen. Springer, Berlin Heidelberg, pp 461-462.
19. DiPaolo T, Payet P, Labrie F (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73: 105-106.
20. Endo M, Daiguji M, Asano Y, Yamashita I, Takahashi S (1978) Periodic psychosis recurring in association with menstrual cycle. J Clin Psychiatry 39: 456-466.
21. Fink G, Sumner BEH (1996) Oestrogen and mental state. Nature 383: 306.
22. Fink G, Sumner BEH, Rosie R, Grace O, Quinn JP (1996) Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16: 325-344.
23. Garcia-Segura LM, Azcoitia I, Don Carlos LL (2001) Neuroprotection by estradiol. Progr Neurobiol 63: 29-60.
24. Gattaz WF, Behrens S, De Vry J, Häfner H (1992) Östradiol hemmt Dopaminvermittelte Verhaltensweisen bei Ratten: Ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr Neurol Psychiatrie 1: 1-44.
25. Gattaz WF, Vogel P, Riecher-Rössler A, Soddu G (1994) Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 36: 137-139.
26. Gerada C, Reveley A (1988) Schizophreniform psychosis associated with the menstrual cycle. Br J Psychiatry 152: 700-702.
27. Glick J, Stewart D (1980) A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 21: 281-287.
28. Gordon JH, Borison RL, Diamond BL (1980) Modulation of dopamine receptors sensitivity by estrogen. Biol Psychiatry 15: 389-396.
29. Gordon JH, Diamond BI (1981) Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 16: 365-371.
30. Gregoire AJP, Kumar R, Everitt B. Henderson AF, Studd JWW (1996) Transdermal oestrogen treatment of severe postnatal depression. Lancet 347: 930-933.
31. Grigoriadis S, Seeman MV (2002) The role of estrogen in schizophrenia: Implications for schizophrenia practice guidelines for women. Can J Psychiatry 47: 437-442.
32. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W (1991a) Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortschr Neurol Psychiatrie 59: 343-360.
33. Häfner H, Behrens S, De Vry J, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991b) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen. Nervenheilkunde 10: 154-163.
34. Häfner H, Behrens S, De Vry J, Gattaz WF (1991c) An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia. Psychiatry Res 38: 125-143.
35. Halbreich U (2002) The spectrum of estrogens, estrogen agonists and SERMS - Abstract. Int J Neuropsychopharmacol 5 (Suppl 1): S12.
36. Hallonquist JD, Seeman MV, Lang M, Rector NA (1993) Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 33: 207-209.
37. Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE (2001) Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry 158: 1134-1139.
38. Holsboer F (1983) Hormones. In: Hippius H, Winokur G (eds) Psychopharmacology 1. Excerpta Medica, Amsterdam Oxford Princeton, 144-161.
39. Honigfeld G, Gillis RD, Klett CJ (1976) NOSIE: Nurses' observation scale for inpatient evaluation. In: Guy W (ed) ECDEU Assessment Manual for Psychopharmocology. Rockville MD, NIMH.
40. Hruska RE, Silbergeld EK (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 61: 397-400.
41. Huber TJ (2001) Hormonspiegel bei Frauen mit psychotischen Erkrankungen. In: Riecher-Rössler A, Rohde A (eds) Psychische Erkrankungen bei Frauen - für eine geschlechtersensible Psychiatrie und Psychotherapie. Karger, Basel Freiburg Paris London New York New Delhi Bangkok Singapore Tokyo Sidney, 165-169.
42. Huber TJ, Rollnik J, Wilhelms J, von zur Mühlen A, Emrich HM, Schneider U (2001) Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26: 27-35.
43. Hutchinson G, Bhugra D, Mallett R, Burnett R, Corridan B, Leff J (1999) Fertility and marital rates in first-onset schizophrenia. Soc Psychiatry Psychiatr Epidemiol 34: 617-621.
44. Jeste DV, Lindamer LA, Lacro JP (2001) Gender differences in late-life schizophrenia and its treatment - Abstract. Syllabus and Proc Summary of the American Psychiatric Association's 2001 Annual Meeting, 310.
45. Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662-673.
46. Klaiber EL, Broverman DM, Vogel U, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36: 550-554.
47. Koller WC, Weiner WJ, Klawans HL, Nausieda PA (1980) Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity. Neuropharmacol 19: 387-391.
48. Kraepelin E (1909) Psychiatrie, vol.1-4, 8th ed. Barth, Leipzig.
49. Krafft-Ebing G (1896) Untersuchungen über Irresein zur Zeit der Menstruation: Ein klinischer Beitrag zur Lehre vom periodischen Irresein. Arch Psychiatry 8: 65-107.
50. Kretschmer E (1921) Körperbau und Charakter. Untersuchungen zum Konstitutionsproblem und zur Lehre von den Temperamenten, 25th ed. Springer, Berlin.
51. Kuhl H (2002) Einfluss von Östrogenen und Gestagenen auf das Zentralnervensystem. In: Kuhl H (ed) Sexualhormone und Psyche. Thieme, Stuttgart, 9-17.
52. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996) A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 20: 247-252.
53. Kulkarni J, Riedel A, de Castella AR et al. (2001) Estrogen - A potential treatment for schizophrenia. Schizophr Res 48: 137-144.
54. Labhart A (1978) Klinik der inneren Sekretion. Springer, Berlin Heidelberg New York.
55. Lindamer LA, Lohr JB, Harris MJ et al. (1997) Gender, estrogen, and schizophrenia. Psychopharmacol Bull 33: 221-228.
56. Lindamer LA, Buse DC, Lohr JB, Jeste DV (2001) Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 49: 47-51.
57. Maguire GA (2002) Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 63 (Suppl 4): 56-62.
58. Mahé V, Dumaine A (2001) Oestrogen withdrawal associated psychoses. Acta Psychiatr Scand 104: 323-331.
59. Mall G (1959) Neuere Ergebnisse der Psycho-Endokrinologie. Ärztliche Praxis XI: 1357-1360.
60. Mall G (1960) Diagnostik und Therapie ovarieller Psychosen. Zentralblatt Gesamte Neurol Psychiatrie 155: 250.
61. McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 34: 251-259.
62. NAMS (2000) A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: Consensus opinion of the North American Menopause Society. Menopause 7: 76-86.
63. Neumann NU, Frasch K (2001) Olanzapin und Schwangerschaft - zwei Kasuistiken. Nervenarzt 72: 876-878.
64. Nicoletti F, Ferrara N, Patti F, Viglianesi M, Rampello L, Bianchi A, Reggio A, Scapagnini U (1983) Influence of sex steroids and prolactin on haloperidol-induced catalepsy. Brain Res 279: 352-358.
65. Oesterlund MK (2002) The role of estrogens in neuropsychiatric disorders. Curr Opin Psychiatry 15: 307-312.
66. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Report 10: 799-812.
67. Rasgon NL, Small GW, Siddarth P, Miller K, Ercoli LM, Bookheimer SY, Lavretsky H, Huang SC, Barrio JR, Phelps ME (2001) Estrogen use and brain metabolic change in older adults. A preliminary report. Psychiatry Research: Neuroimaging Section 107: 11-18.
68. Riecher A, Maurer K, Löffler W, Fätkenheuer B, an der Heiden W, Munk-Jørgensen P, Strömgren E, Häfner H (1990) Gender differences in age at onset and course of schizophrenic disorders. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol. 2, 15-33.
69. Riecher-Rössler A, Häfner H (1993) Schizophrenia and oestrogens - is there an association? Euro Arch Psychiatry Clin Neurosci 242: 323-328.
70. Riecher-Rössler A (1994) Die Spätschizophrenie - eine valide Entität? Eine empirische Studie zu Risikofaktoren, Krankheitsbild und Verlauf. Habilitationsschrift, Universität Heidelberg-Mannheim.
71. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R (1994a) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20: 203-214.
72. Riecher-Rössler A, Häfner H, Dütsch-Strobel A, Oster M, Stumbaum M, van Gülick-Bailer M, Löffler W (1994b) Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 36: 492-494.
73. Riecher-Rössler A, Löffler W, Munk-Jørgensen P (1997) What do we really know about late-onset schizophrenia? Eur Arch Psychiatry Clin Neurosci 247: 195-208.
74. Riecher-Rössler A, Häfner H, Dütsch-Strobel A, Stumbaum M (1998) Gonadal function and its influence on psychopathology. A comparison of schizophrenic and non-schizophrenic female inpatients. Arch Women Ment Health 1: 15-26.
75. Riecher-Rössler A (2002) Estrogen effects in schizophrenia and their potential therapeutic implications - review. Arch Women Ment Health 5: 111-118.
76. Riecher-Rössler A (2003) Estrogens and schizophrenia. Curr Opin Psychiatry 16: 187-192.
77. Ripley HS, Papanicolaou GN (1942) The menstrual cycle with vaginal smear studies in schizophrenia, depression and elation. Am J Psychiatry 98: 567-573.
78. Schepp A (1997) Pilotstudie zur Frage eines überdauernden relativen Hypoöstrogenismus bei schizophrenen Frauen. Inauguraldissertation zur Erlangung des medizinischen Doktorgrades, Universität Heidelberg-Mannheim.
79. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecology 183: 414-420.
80. Scriba PC, von Werder K (1976) Hypothalamus und Hypophyse. In: Siegenthaler W (ed) Klinische Pathophysiologie. Thieme, Stuttgart, pp 278-306.
81. Seeman MV (1983) Interaction of sex, age and neuroleptic dose. Compr Psychiatry 24: 125-128.
82. Sichel DA, Cohen LS, Robertson LM et al. (1995) Prophylactic estrogen in recurrent postpartum affective disorders. Biol Psychiatry 38: 814-818.
83. Smith S, Wheeler MJ, Murray R, O'Keane V (2002) The effects of antipsychoticinduced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 22: 109-114.
84. Stahl SM (1998) Basic psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 59 (Suppl 4): 15-24.
85. Stahl SM (2001a) Effects of estrogen on the central nervous system. J Clin Psychiatry 62: 317-318.
86. Stahl SM (2001b) Why drugs and hormones may interact in psychiatric disorders. J Clin Psychiatry 62: 225-226.
87. von Zerssen D, Koeller DM (1976) Klinische Selbstbeurteilungs-Skalen (KSb-Si) aus dem Münchener Psychiatrischen Informations-System (PSYCHIS München). Manual. Beltz, Weinheim.
88. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321-333.
89. Zhang-Wong J, Seeman MV (2002) Antipsychotic drugs, menstrual regularity, and osteoporosis risk. Arch Women Ment Health 5: 93-98.
90. Zweifel JE, O'Brien WH (1997) A meta-Analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189-212.